公共卫生中的CRISPR:基因编辑研究和应用的健康公平影响及社区作用
本文介绍CRISPR基因编辑技术及其潜在公共卫生效益(如改善病毒监测、治愈镰状细胞贫血等公共卫生问题相关的遗传病),同时概述对健康公平的若干重大伦理与实践威胁,包括少数群体在基因组学研究中的严重代表性不足,以及其在医疗中预计将面临的不平等可及性;文章认为,确保基因编辑促进而非削弱健康公平,需采用社区参与式研究方法,使少数群体患者和人群有意义地居于基因编辑研究的中心并参与其中。
要点
- CRISPR在公共卫生领域潜力显著,但仅靶向遗传因素对人群健康影响有限。
- 少数群体在基因组学研究中严重代表性不足,可能导致CRISPR工具和疗法对其效果与接受度较差。
- 确保基因编辑促进健康公平,需采用社区参与式研究方法使少数群体有意义地参与。
核心结论
- 确保基因编辑促进而非削弱健康公平,需采用社区参与式研究方法,使少数群体患者和人群有意义地居于基因编辑研究的中心并参与其中。
研究设计与样本
- 本文为公共卫生领域文章,介绍CRISPR及其潜在公共卫生效益,并概述对健康公平的伦理与实践威胁。
主要发现
- 仅靶向遗传因素对人群健康影响有限。
- 少数群体(种族/族裔、性与性别)历史上从新兴医疗创新和工具中获得的益处不平等。
- 少数群体在基因组学研究中严重代表性不足,可能导致CRISPR工具和疗法对这些群体效果较差且接受度较低。
- 少数群体在医疗中对这些工具和疗法预计将面临不平等可及性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CRISPR (clustered regularly interspaced short palindromic repeats) is a Nobel Prize-winning technology that holds significant promise for revolutionizing the prevention and treatment of human disease through gene editing. However, CRISPR's public health implications remain relatively uncertain and underdiscussed because (1) targeting genetic factors alone will have limited influence on population health, and (2) minority populations (racial/ethnic, sexual and gender)-who bear the nation's greatest health burdens-historically suffer unequal benefits from emerging health care innovations and tools. This article introduces CRISPR and its potential public health benefits (e.g., improving virus surveillance, curing genetic diseases that pose public health problems such as sickle cell anemia) while outlining several major ethical and practical threats to health equity. This includes minorities' grave underrepresentation in genomics research, which may lead to less effective and accepted CRISPR tools and therapies for these groups, and their anticipated unequal access to these tools and therapies in health care. Informed by the principles of fairness, justice, and equitable access, ensuring gene editing promotes rather than diminishes health equity will require the meaningful centering and engagement of minority patients and populations in gene-editing research using community-based participatory research approaches. (Am J Public Health. 2023;113(8):874-882. https://doi.org/10.2105/AJPH.2023.307315).
引用
- Subica AM. CRISPR in Public Health: The Health Equity Implications and Role of Community in Gene-Editing Research and Applications. Am J Public Health. 2023. PMID: 37200601. doi:10.2105/AJPH.2023.307315
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。